Fresia Pareja, Rohit Bhargava, Virginia F Borges, Edi Brogi, Rita Canas Marques, Fatima Cardoso, Christine Desmedt, Malini Harigopal, Sunil R Lakhani, Adrian Lee, Jose Pablo Leone, Hannah Linden, Christopher J Lord, Caterina Marchio, Sofia D Merajver, Emad Rakha, Jorge S Reis-Filho, Andrea Richardson, Elinor Sawyer, Pepper Schedin, Christopher J Schwartz, Andrew Tutt, Naoto T Ueno, Anne Vincent-Salomon, Britta Weigelt, Y Hannah Wen, Stuart J Schnitt, Steffi Oesterreich
{"title":"Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes.","authors":"Fresia Pareja, Rohit Bhargava, Virginia F Borges, Edi Brogi, Rita Canas Marques, Fatima Cardoso, Christine Desmedt, Malini Harigopal, Sunil R Lakhani, Adrian Lee, Jose Pablo Leone, Hannah Linden, Christopher J Lord, Caterina Marchio, Sofia D Merajver, Emad Rakha, Jorge S Reis-Filho, Andrea Richardson, Elinor Sawyer, Pepper Schedin, Christopher J Schwartz, Andrew Tutt, Naoto T Ueno, Anne Vincent-Salomon, Britta Weigelt, Y Hannah Wen, Stuart J Schnitt, Steffi Oesterreich","doi":"10.1038/s41523-025-00719-w","DOIUrl":null,"url":null,"abstract":"<p><p>Special histologic subtypes of breast cancer (BC) exhibit unique phenotypes and molecular profiles with diagnostic and therapeutic implications, often differing in behavior and clinical trajectory from common BC forms. Novel methodologies, such as artificial intelligence may improve classification. Genetic predisposition plays roles in a subset of cases. Uncommon BC presentations like male, inflammatory and pregnancy-related BC pose challenges. Emerging therapeutic strategies targeting genetic alterations or immune microenvironment are being explored.</p>","PeriodicalId":19247,"journal":{"name":"NPJ Breast Cancer","volume":"11 1","pages":"6"},"PeriodicalIF":6.5000,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11760369/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Breast Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41523-025-00719-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Special histologic subtypes of breast cancer (BC) exhibit unique phenotypes and molecular profiles with diagnostic and therapeutic implications, often differing in behavior and clinical trajectory from common BC forms. Novel methodologies, such as artificial intelligence may improve classification. Genetic predisposition plays roles in a subset of cases. Uncommon BC presentations like male, inflammatory and pregnancy-related BC pose challenges. Emerging therapeutic strategies targeting genetic alterations or immune microenvironment are being explored.
期刊介绍：
npj Breast Cancer publishes original research articles, reviews, brief correspondence, meeting reports, editorial summaries and hypothesis generating observations which could be unexplained or preliminary findings from experiments, novel ideas, or the framing of new questions that need to be solved. Featured topics of the journal include imaging, immunotherapy, molecular classification of disease, mechanism-based therapies largely targeting signal transduction pathways, carcinogenesis including hereditary susceptibility and molecular epidemiology, survivorship issues including long-term toxicities of treatment and secondary neoplasm occurrence, the biophysics of cancer, mechanisms of metastasis and their perturbation, and studies of the tumor microenvironment.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
